Emcure Pharmaceuticals Company Description

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.

It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.

Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss.

Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Emcure Pharmaceuticals Limited

Country	India
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	6,731
CEO	Satish Mehta

Contact Details

Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India
Phone	91 20 3507 0033
Website	emcure.com

Stock Details

Ticker Symbol	EMCURE
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE168P01015
SIC Code	2834

Key Executives

Name	Position
Satish Ramanlal Mehta	Chief Executive Officer, MD and Executive Director
Samit Satish Mehta	President of Operations and Whole-Time Director
Dr. Mukund Keshao Gurjar	Chief Scientific Officer and Whole-Time Director
Sunil Rajanikant Mehta	Executive Director of Projects and Whole-Time Director
Namita Vikas Thapar	Executive Director of India Business and Whole-Time Director
Tajuddin Sabir Shaikh	Chief Financial Officer
Chetan Rajendra Sharma	Company Secretary and Compliance Officer
Naveen Soni	Director of Corporate Communications and Public Relations
Vikas Madan Thapar	President of Corporate Development, Strategy and Finance
Rajesh Nair	President of Human Resources